298 related articles for article (PubMed ID: 17885215)
1. Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway.
Yang XP; Mattagajasingh S; Su S; Chen G; Cai Z; Fox-Talbot K; Irani K; Becker LC
Circ Res; 2007 Nov; 101(10):1001-8. PubMed ID: 17885215
[TBL] [Abstract][Full Text] [Related]
2. Fractalkine promotes chemotaxis of bone marrow-derived mesenchymal stem cells towards ischemic brain lesions through Jak2 signaling and cytoskeletal reorganization.
Zhang Y; Zheng J; Zhou Z; Zhou H; Wang Y; Gong Z; Zhu J
FEBS J; 2015 Mar; 282(5):891-903. PubMed ID: 25559502
[TBL] [Abstract][Full Text] [Related]
3. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of CCL15 expression and monocyte adhesion to endothelial cells (ECs) after hypoxia/reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs.
Park KH; Lee TH; Kim CW; Kim J
J Immunol; 2013 Jun; 190(12):6550-8. PubMed ID: 23690481
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway.
Huang L; Ma B; Ma J; Wang F
Biochem Biophys Res Commun; 2017 Dec; 493(4):1510-1517. PubMed ID: 28986258
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine upregulates inflammation through CX3CR1 and the Jak-Stat pathway in severe acute pancreatitis rat model.
Huang LY; Chen P; Xu LX; Zhou YF; Zhang YP; Yuan YZ
Inflammation; 2012 Jun; 35(3):1023-30. PubMed ID: 22213034
[TBL] [Abstract][Full Text] [Related]
8. Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin.
Zanchi C; Zoja C; Morigi M; Valsecchi F; Liu XY; Rottoli D; Locatelli M; Buelli S; Pezzotta A; Mapelli P; Geelen J; Remuzzi G; Hawiger J
J Immunol; 2008 Jul; 181(2):1460-9. PubMed ID: 18606701
[TBL] [Abstract][Full Text] [Related]
9. Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.
Sans M; Danese S; de la Motte C; de Souza HS; Rivera-Reyes BM; West GA; Phillips M; Katz JA; Fiocchi C
Gastroenterology; 2007 Jan; 132(1):139-53. PubMed ID: 17241867
[TBL] [Abstract][Full Text] [Related]
10. Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells.
Silverman MD; Zamora DO; Pan Y; Texeira PV; Baek SH; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1608-15. PubMed ID: 12657599
[TBL] [Abstract][Full Text] [Related]
11. Fractalkine stimulates cell growth and increases its expression via NF-κB pathway in RA-FLS.
Guo X; Pan Y; Xiao C; Wu Y; Cai D; Gu J
Int J Rheum Dis; 2012 Jun; 15(3):322-9. PubMed ID: 22709495
[TBL] [Abstract][Full Text] [Related]
12. Signal transducer and activator of transcription 3alpha and specificity protein 1 interact to upregulate intercellular adhesion molecule-1 in ischemic-reperfused myocardium and vascular endothelium.
Yang XP; Irani K; Mattagajasingh S; Dipaula A; Khanday F; Ozaki M; Fox-Talbot K; Baldwin WM; Becker LC
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1395-400. PubMed ID: 15860735
[TBL] [Abstract][Full Text] [Related]
13. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms.
Goda S; Imai T; Yoshie O; Yoneda O; Inoue H; Nagano Y; Okazaki T; Imai H; Bloom ET; Domae N; Umehara H
J Immunol; 2000 Apr; 164(8):4313-20. PubMed ID: 10754331
[TBL] [Abstract][Full Text] [Related]
14. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice.
Staniland AA; Clark AK; Wodarski R; Sasso O; Maione F; D'Acquisto F; Malcangio M
J Neurochem; 2010 Aug; 114(4):1143-57. PubMed ID: 20524966
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of CD16(+) monocytes to endothelial cells in response to LPS-treatment and concomitant TNF release is regulated by CX3CR1 and interfered by soluble fractalkine.
Rennert K; Heisig K; Groeger M; Wallert M; Funke H; Lorkowski S; Huber O; Mosig AS
Cytokine; 2016 Jul; 83():41-52. PubMed ID: 27031442
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice.
Song KH; Park J; Park JH; Natarajan R; Ha H
Diabetologia; 2013 Jul; 56(7):1661-9. PubMed ID: 23604552
[TBL] [Abstract][Full Text] [Related]
17. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions.
Ancuta P; Moses A; Gabuzda D
Immunobiology; 2004; 209(1-2):11-20. PubMed ID: 15481136
[TBL] [Abstract][Full Text] [Related]
18. Fractalkine/CX3CR1 signalling in chronic pain and inflammation.
Clark AK; Staniland AA; Malcangio M
Curr Pharm Biotechnol; 2011 Oct; 12(10):1707-14. PubMed ID: 21466443
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.
Gan AM; Butoi ED; Manea A; Simion V; Stan D; Parvulescu MM; Calin M; Manduteanu I; Simionescu M
Cell Tissue Res; 2013 Jan; 351(1):161-74. PubMed ID: 23086480
[TBL] [Abstract][Full Text] [Related]
20. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection.
Robinson LA; Nataraj C; Thomas DW; Howell DN; Griffiths R; Bautch V; Patel DD; Feng L; Coffman TM
J Immunol; 2000 Dec; 165(11):6067-72. PubMed ID: 11086038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]